This inventor holds 1 USPTO granted patent. Top assignee: M.i.t.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Regine Labeque: Innovator in Lipoprotein Removal
Introduction
Regine Labeque is a notable inventor based in Wakefield, MA (US). She has made significant contributions to the field of biochemistry, particularly in the area of lipoprotein removal. Her innovative work focuses on therapeutic methods to lower low-density lipoproteins (LDL) in the bloodstream.
Latest Patents
Regine Labeque holds a patent for "Lipoprotein removal by soluble enzymes." This patent describes a therapeutically effective amount of soluble phospholipase A₂ administered to a subject to lower LDL levels in the blood. The process involves modifying plasma LDL by hydrolyzing the phospholipids present in LDL, which allows for the rapid removal of modified LDL from the bloodstream through catabolic processes. She has 1 patent to her name.
Career Highlights
Regine Labeque is associated with the Massachusetts Institute of Technology (MIT), where she has contributed to various research initiatives. Her work has been instrumental in advancing therapeutic strategies for cardiovascular health.
Collaborations
Some of her notable coworkers include Robert S. Lees and Robert Samuel Langer. Their collaborative efforts have further enhanced the impact of her research in the scientific community.
Conclusion
Regine Labeque's innovative approach to lipoprotein removal showcases her dedication to improving health outcomes through scientific research. Her contributions continue to influence the field of biochemistry and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile